MRSA Research - Methicillin-Resistant Staphylococcus Aureus, Hospitals, Infection, Antibiotic Resistance, Superbugs

MRSA Research Today is a free monthly online journal that collates and summarizes the latest research about MRSA, including details on methicillin-resistant staphylococcus aureus, hospitals, infection, antibiotic resistance, superbugs.


MRSA Research Today

Home

View Latest Issue

Information About MRSA

Books on MRSA

Advertising in Research Today

View Other Research Today Publications



Volume 7 (2010), Issue 11 (November)

  1. First outbreak of methicillin-resistant Staphylococcus aureus USA300 harboring the Panton-Valentine leukocidin genes among Japanese health care workers and hospitalized patients.
    Am J Infect Control, 38(9): e37-9. [Abstract] [Full-text]
  2. Bacteremia in Staphylococcus aureus pneumonia: Outcomes and epidemiology.
    J Crit Care. [Abstract] [Full-text]
  3. Antibacterial efficacy of silver nanoparticles of different sizes, surface conditions and synthesis methods.
    Nanotoxicology. [Abstract] [Full-text]
  4. Characterization of Toxin Genes and Antimicrobial Susceptibility of Staphylococcus aureus Isolates from Louisiana Retail Meats.
    Foodborne Pathog Dis. [Abstract] [Full-text]
  5. Antimicrobial Susceptibility of Staphylococcus aureus and Characterization of Methicillin-Resistant Staphylococcus aureus Isolated from Bovine Mastitis in Korea.
    Foodborne Pathog Dis. [Abstract] [Full-text]
  6. Detection of meticillin-resistant staphylococcus aureus (MRSA) colonization in newborn infants using real-time polymerase chain reaction (PCR).
    Acta Paediatr, 99(11): 1691-4. [Abstract] [Full-text]
  7. Universal MRSA nasal surveillance: characterization of outcomes at a tertiary care center and implications for infection control.
    South Med J, 103(11): 1084-91. [Abstract] [Full-text]
  8. Vancomycin MIC susceptibility testing of methicillin-susceptible and methicillin-resistant Staphylococcus aureus isolates: a comparison between Etest® and an automated testing method.
    South Med J, 103(11): 1124-8. [Abstract] [Full-text]
  9. Antibiotic resistance and otomycosis in the draining ear: culture results by diagnosis.
    Am J Otolaryngol. [Abstract] [Full-text]
  10. Antibacterial activity of Lactobacillus acidophilus and Lactobacillus casei against methicillin-resistant Staphylococcus aureus (MRSA).
    Microbiol Res, 165(8): 674-86. [Abstract] [Full-text]
  11. A novel missense mutation in the nuclear factor-κB essential modulator (NEMO) gene resulting in impaired activation of the NF-κB pathway and a unique clinical phenotype presenting as MRSA subdural empyema.
    J Clin Immunol, 30(6): 881-5. [Abstract] [Full-text]
  12. The effectiveness of an improved combination therapy for experimental Staphylococcus aureus keratitis.
    Adv Ther. [Abstract] [Full-text]
  13. High prevalence of ST121 in community-associated methicillin-susceptible Staphylococcus aureus lineages responsible for skin and soft tissue infections in Portuguese children.
    Eur J Clin Microbiol Infect Dis. [Abstract] [Full-text]
  14. Staphylococcus aureus phage types and their correlation to antibiotic resistance.
    Indian J Pathol Microbiol, 53(4): 738-41. [Abstract] [Full-text]
  15. Cationic porphycenes as potential photosensitizers for antimicrobial photodynamic therapy.
    J Med Chem, 53(21): 7796-803. [Abstract] [Full-text]
  16. Chlorhexidine-impregnated cloths to prevent skin and soft-tissue infection in Marine recruits: a cluster-randomized, double-blind, controlled effectiveness trial.
    Infect Control Hosp Epidemiol, 31(12): 1207-15. [Abstract] [Full-text]
  17. Improving efficiency in active surveillance for methicillin-resistant Staphylococcus aureus or vancomycin-resistant Enterococcus at hospital admission.
    Infect Control Hosp Epidemiol, 31(12): 1230-5. [Abstract] [Full-text]
  18. Staphylococcal superantigens cause lethal pulmonary disease in rabbits.
    J Infect Dis, 202(11): 1690-7. [Abstract] [Full-text]
  19. Increasing threat of community-acquired methicillin-resistant Staphylococcus aureus.
    Am J Med Sci, 340(5): 378-81. [Abstract] [Full-text]
  20. A Novel Bacteriophage Lysin, LysGH15, Protects a Murine Bacteremia Model Efficiently against Lethal Methicillin-Resistant Staphylococcus aureus Infection.
    J Clin Microbiol. [Abstract] [Full-text]
  21. Comparison of Detection Methods for Heteroresistant Vancomycin Intermediate Staphylococcus aureus (hVISA) using Population Analysis Profile as the Reference Method.
    J Clin Microbiol. [Abstract] [Full-text]
  22. Chlorhexidine-impregnated cloths to prevent skin and soft-tissue infection in Marine recruits: a cluster-randomized, double-blind, controlled effectiveness trial.
    Infect Control Hosp Epidemiol, 31(12): 1207-15. [Abstract] [Full-text]
  23. Improving efficiency in active surveillance for methicillin-resistant Staphylococcus aureus or vancomycin-resistant Enterococcus at hospital admission.
    Infect Control Hosp Epidemiol, 31(12): 1230-5. [Abstract] [Full-text]
  24. Staphylococcal superantigens cause lethal pulmonary disease in rabbits.
    J Infect Dis, 202(11): 1690-7. [Abstract] [Full-text]
  25. Cationic porphycenes as potential photosensitizers for antimicrobial photodynamic therapy.
    J Med Chem, 53(21): 7796-803. [Abstract] [Full-text]
  26. Chlorhexidine-impregnated cloths to prevent skin and soft-tissue infection in Marine recruits: a cluster-randomized, double-blind, controlled effectiveness trial.
    Infect Control Hosp Epidemiol, 31(12): 1207-15. [Abstract] [Full-text]
  27. Improving efficiency in active surveillance for methicillin-resistant Staphylococcus aureus or vancomycin-resistant Enterococcus at hospital admission.
    Infect Control Hosp Epidemiol, 31(12): 1230-5. [Abstract] [Full-text]
  28. Staphylococcal superantigens cause lethal pulmonary disease in rabbits.
    J Infect Dis, 202(11): 1690-7. [Abstract] [Full-text]
  29. Risk factors for infection and colonization with community-associated methicillin-resistant Staphylococcus aureus in the Los Angeles County jail: a case-control study.
    Clin Infect Dis, 51(11): 1248-57. [Abstract] [Full-text]
  30. Synthetic Lethal Compound Combinations Reveal a Fundamental Connection between Wall Teichoic Acid and Peptidoglycan Biosyntheses in Staphylococcus aureus.
    ACS Chem Biol. [Abstract] [Full-text]
  31. Comparative activity of ceftobiprole against Gram-positive and Gram-negative isolates from Europe and the Middle East: the CLASS study.
    J Antimicrob Chemother. [Abstract] [Full-text]
  32. Risk factors for infection and colonization with community-associated methicillin-resistant Staphylococcus aureus in the Los Angeles County jail: a case-control study.
    Clin Infect Dis, 51(11): 1248-57. [Abstract] [Full-text]
  33. Synthetic Lethal Compound Combinations Reveal a Fundamental Connection between Wall Teichoic Acid and Peptidoglycan Biosyntheses in Staphylococcus aureus.
    ACS Chem Biol. [Abstract] [Full-text]
  34. Risk factors for infection and colonization with community-associated methicillin-resistant Staphylococcus aureus in the Los Angeles County jail: a case-control study.
    Clin Infect Dis, 51(11): 1248-57. [Abstract] [Full-text]
  35. Toxic epidermal necrolysis: retrospective analysis of 21 consecutive cases managed at a tertiary centre.
    Clin Exp Dermatol, 35(8): 853-62. [Abstract] [Full-text]
  36. Association of methicillin-resistant Staphylococcus aureus (MRSA) USA300 genotype with mortality in MRSA Bacteremia.
    J Infect, 61(5): 372-81. [Abstract] [Full-text]
  37. A classification system for hospital-based infection outbreaks.
    Comput Math Methods Med, 11(4): 297-311. [Abstract] [Full-text]
  38. Molecular Analysis Improves Pathogen Identification and Epidemiologic Study of Pediatric Parapneumonic Empyema.
    Pediatr Infect Dis J. [Abstract] [Full-text]
  39. Trimethoprim-sulfamethoxazole or clindamycin for community-associated MRSA (CA-MRSA) skin infections.
    J Am Board Fam Med, 23(6): 714-9. [Abstract] [Full-text]
  40. Molecular Analysis Improves Pathogen Identification and Epidemiologic Study of Pediatric Parapneumonic Empyema.
    Pediatr Infect Dis J. [Abstract] [Full-text]
  41. A classification system for hospital-based infection outbreaks.
    Comput Math Methods Med, 11(4): 297-311. [Abstract] [Full-text]
  42. Toxic epidermal necrolysis: retrospective analysis of 21 consecutive cases managed at a tertiary centre.
    Clin Exp Dermatol, 35(8): 853-62. [Abstract] [Full-text]
  43. A classification system for hospital-based infection outbreaks.
    Comput Math Methods Med, 11(4): 297-311. [Abstract] [Full-text]
  44. Toxic epidermal necrolysis: retrospective analysis of 21 consecutive cases managed at a tertiary centre.
    Clin Exp Dermatol, 35(8): 853-62. [Abstract] [Full-text]
  45. Binary IS typing for Staphylococcus aureus.
    PLoS One, 5(10): e13671. [Abstract] [Full-text]
  46. MRSA and cataract surgery - reflections for practice.
    Clin Ophthalmol, 4: 1223-7. [Abstract] [Full-text]
  47. Sustained reduction in antimicrobial use and decrease in methicillin-resistant Staphylococcus aureus and Clostridium difficile infections following implementation of an electronic medical record at a tertiary-care teaching hospital.
    J Antimicrob Chemother. [Abstract] [Full-text]
  48. Comparison of real-time PCR with disk diffusion, agar screen and E-test methods for detection of methicillin-resistant Staphylococcus aureus.
    Curr Microbiol, 61(6): 520-4. [Abstract] [Full-text]
  49. Importance of appropriate empirical antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteraemia.
    J Antimicrob Chemother, 65(12): 2658-65. [Abstract] [Full-text]
  50. High prevalence of the arginine catabolic mobile element in carriage isolates of methicillin-resistant Staphylococcus epidermidis.
    J Antimicrob Chemother. [Abstract] [Full-text]
  51. Importance of appropriate empirical antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteraemia.
    J Antimicrob Chemother, 65(12): 2658-65. [Abstract] [Full-text]
  52. Comparison of real-time PCR with disk diffusion, agar screen and E-test methods for detection of methicillin-resistant Staphylococcus aureus.
    Curr Microbiol, 61(6): 520-4. [Abstract] [Full-text]
  53. Importance of appropriate empirical antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteraemia.
    J Antimicrob Chemother, 65(12): 2658-65. [Abstract] [Full-text]
  54. Comparison of real-time PCR with disk diffusion, agar screen and E-test methods for detection of methicillin-resistant Staphylococcus aureus.
    Curr Microbiol, 61(6): 520-4. [Abstract] [Full-text]
  55. Chemical composition, antioxidant and antibacterial properties of the essential oils of Etlingera elatior and Cinnamomum pubescens Kochummen.
    J Sci Food Agric, 90(15): 2682-8. [Abstract] [Full-text]
  56. Antimicrobial Resistance in Hispanic Patients Hospitalized in San Antonio, TX with Community-Acquired Pneumonia.
    Hosp Pract (Minneap), 38(4): 108-13. [Abstract] [Full-text]
  57. Chemical composition, antioxidant and antibacterial properties of the essential oils of Etlingera elatior and Cinnamomum pubescens Kochummen.
    J Sci Food Agric, 90(15): 2682-8. [Abstract] [Full-text]
  58. Chemical composition, antioxidant and antibacterial properties of the essential oils of Etlingera elatior and Cinnamomum pubescens Kochummen.
    J Sci Food Agric, 90(15): 2682-8. [Abstract] [Full-text]
  59. Mortality in patients with meticillin-resistant Staphylococcus aureus bacteraemia, England 2004-2005.
    J Hosp Infect. [Abstract] [Full-text]
  60. Tuning hydrophobicity of highly cationic tetradecameric Gramicidin S analogues using adamantane amino acids.
    Bioorg Med Chem, 18(23): 8403-9. [Abstract] [Full-text]
  61. Simultaneous Carriage of Multiple Genotypes of Staphylococcus aureus in Children.
    J Med Microbiol. [Abstract] [Full-text]
  62. The effects of subinhibitory concentrations of costus oil on virulence factor production in Staphylococcus aureus.
    J Appl Microbiol. [Abstract] [Full-text]
  63. Children with Atopic Dermatitis Appear Less Likely to Be Infected with Community Acquired Methicillin-Resistant Staphylococcus aureus: The San Diego Experience.
    Pediatr Dermatol. [Abstract] [Full-text]
  64. Characteristics of Staphylococcus aureus colonization in patients with atopic dermatitis in Sri Lanka.
    Clin Exp Dermatol. [Abstract] [Full-text]
  65. Antimicrobial, antimalarial, and antileishmanial activities of mono- and bis-quaternary pyridinium compounds.
    Chem Biol Drug Des, 76(6): 546-51. [Abstract] [Full-text]
  66. Potential action of copper surfaces on meticillin-resistant Staphylococcus aureus.
    J Appl Microbiol, 109(6): 2200-5. [Abstract] [Full-text]
  67. Simultaneous Carriage of Multiple Genotypes of Staphylococcus aureus in Children.
    J Med Microbiol. [Abstract] [Full-text]
  68. Children with Atopic Dermatitis Appear Less Likely to Be Infected with Community Acquired Methicillin-Resistant Staphylococcus aureus: The San Diego Experience.
    Pediatr Dermatol. [Abstract] [Full-text]
  69. Characteristics of Staphylococcus aureus colonization in patients with atopic dermatitis in Sri Lanka.
    Clin Exp Dermatol. [Abstract] [Full-text]
  70. Antimicrobial, antimalarial, and antileishmanial activities of mono- and bis-quaternary pyridinium compounds.
    Chem Biol Drug Des, 76(6): 546-51. [Abstract] [Full-text]
  71. Potential action of copper surfaces on meticillin-resistant Staphylococcus aureus.
    J Appl Microbiol, 109(6): 2200-5. [Abstract] [Full-text]
  72. Tuning hydrophobicity of highly cationic tetradecameric Gramicidin S analogues using adamantane amino acids.
    Bioorg Med Chem, 18(23): 8403-9. [Abstract] [Full-text]
  73. Antimicrobial, antimalarial, and antileishmanial activities of mono- and bis-quaternary pyridinium compounds.
    Chem Biol Drug Des, 76(6): 546-51. [Abstract] [Full-text]
  74. Potential action of copper surfaces on meticillin-resistant Staphylococcus aureus.
    J Appl Microbiol, 109(6): 2200-5. [Abstract] [Full-text]
  75. Tuning hydrophobicity of highly cationic tetradecameric Gramicidin S analogues using adamantane amino acids.
    Bioorg Med Chem, 18(23): 8403-9. [Abstract] [Full-text]
  76. Rapid screening of methicillin-resistant Staphylococcus aureus using PCR and chromogenic agar: a prospective study to evaluate costs and effects.
    Clin Microbiol Infect, 16(12): 1754-61. [Abstract] [Full-text]
  77. Cost-effectiveness of universal MRSA screening on admission to surgery.
    Clin Microbiol Infect, 16(12): 1747-53. [Abstract] [Full-text]
  78. Risk factors for carbapenem-resistant Acinetobacter baumannii infections at a tertiary care hospital in New Caledonia, South Pacific.
    Scand J Infect Dis, 42(11): 821-6. [Abstract] [Full-text]
  79. Cost-effectiveness of adding decolonization to a surveillance strategy of screening and isolation for methicillin-resistant Staphylococcus aureus carriers.
    Clin Microbiol Infect, 16(12): 1740-6. [Abstract] [Full-text]
  80. Molecular picture of community- and healthcare-associated methicillin-resistant Staphylococcus aureus circulating in a teaching hospital in Milan.
    Scand J Infect Dis, 42(11): 873-8. [Abstract] [Full-text]
  81. Comparative efficacies of human simulated exposures of telavancin and vancomycin against methicillin-resistant Staphylococcus aureus with a range of vancomycin MICs in a murine pneumonia model.
    Antimicrob Agents Chemother, 54(12): 5115-9. [Abstract] [Full-text]
  82. Nasal carriage of methicillin-resistant and methicillin-sensitive strains of Staphylococcus sciuri in the Indonesian population.
    Antimicrob Agents Chemother, 54(12): 5413-7. [Abstract] [Full-text]
  83. An RpoB mutation confers dual heteroresistance to daptomycin and vancomycin in Staphylococcus aureus.
    Antimicrob Agents Chemother, 54(12): 5222-33. [Abstract] [Full-text]
  84. Costs of healthcare-associated methicillin-resistant Staphylococcus aureus and its control.
    Clin Microbiol Infect, 16(12): 1721-8. [Abstract] [Full-text]
  85. Fusidic acid resistance determinants in Staphylococcus aureus clinical isolates.
    Antimicrob Agents Chemother, 54(12): 4985-91. [Abstract] [Full-text]
  86. Decline in the incidence of healthcare-associated methicillin-resistant Staphylococcus aureus (HA-MRSA) correlates with deceased antimicrobial consumption at a tertiary care hospital in Taiwan, 2001-2009.
    Int J Antimicrob Agents, 36(6): 523-30. [Abstract] [Full-text]
  87. Efficacy of daptomycin combined with rifampicin for the treatment of experimental meticillin-resistant Staphylococcus aureus (MRSA) acute osteomyelitis.
    Int J Antimicrob Agents, 36(6): 542-4. [Abstract] [Full-text]
  88. Efficacy of usual and high doses of daptomycin in combination with rifampin versus alternative therapies in experimental foreign-body infection by methicillin-resistant Staphylococcus aureus.
    Antimicrob Agents Chemother, 54(12): 5251-6. [Abstract] [Full-text]
  89. Novel daptomycin combinations against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus in an in vitro model of simulated endocardial vegetations.
    Antimicrob Agents Chemother, 54(12): 5187-92. [Abstract] [Full-text]
  90. Identification and characterization of the multidrug resistance gene cfr in a Panton-Valentine leukocidin-positive sequence type 8 methicillin-resistant Staphylococcus aureus IVa (USA300) isolate.
    Antimicrob Agents Chemother, 54(12): 4978-84. [Abstract] [Full-text]
  91. In vivo pharmacodynamic activity of tomopenem (formerly CS-023) against Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus in a murine thigh infection model.
    Antimicrob Agents Chemother, 54(12): 5298-302. [Abstract] [Full-text]
  92. Identification of the plasmid-encoded qacA efflux pump gene in meticillin-resistant Staphylococcus aureus (MRSA) strain HPV107, a representative of the MRSA Iberian clone.
    Int J Antimicrob Agents, 36(6): 557-61. [Abstract] [Full-text]
  93. Phylogenetic analysis and antimicrobial activities of Streptomyces isolates from mangrove sediment.
    J Basic Microbiol. [Abstract] [Full-text]
  94. Nasal carriage of Staphylococcus aureus in healthy humans with different levels of contact with animals in Tunisia: genetic lineages, methicillin resistance, and virulence factors.
    Eur J Clin Microbiol Infect Dis. [Abstract] [Full-text]
  95. Methicillin-resistant Staphylococcus-aureus-associated glomerulonephritis on the decline: decreased incidence since the 1990s.
    Clin Exp Nephrol. [Abstract] [Full-text]
  96. Community-acquired methicillin-resistant Staphylococcus aureus: an ongoing challenge for WOC nursing.
    J Wound Ostomy Continence Nurs, 37(6): 633-8. [Abstract] [Full-text]
  97. Inhibition of efflux pumps in meticillin-resistant Staphylococcus aureus and Enterococcus faecalis resistant strains by triterpenoids from Momordica balsamina.
    Int J Antimicrob Agents. [Abstract] [Full-text]
  98. MRSA CC398 in the pig production chain.
    Prev Vet Med. [Abstract] [Full-text]
  99. Staphylococcus aureus sinus infections in children.
    Int J Pediatr Otorhinolaryngol. [Abstract] [Full-text]
  100. Post-surgical wound infections involving Enterobacteriaceae with reduced susceptibility to β-lactams in two Portuguese hospitals.
    Int Wound J, 7(6): 508-14. [Abstract] [Full-text]
  101. Phylogenetic analysis and antimicrobial activities of Streptomyces isolates from mangrove sediment.
    J Basic Microbiol. [Abstract] [Full-text]
  102. Nasal carriage of Staphylococcus aureus in healthy humans with different levels of contact with animals in Tunisia: genetic lineages, methicillin resistance, and virulence factors.
    Eur J Clin Microbiol Infect Dis. [Abstract] [Full-text]
  103. Methicillin-resistant Staphylococcus-aureus-associated glomerulonephritis on the decline: decreased incidence since the 1990s.
    Clin Exp Nephrol. [Abstract] [Full-text]
  104. MRSA CC398 in the pig production chain.
    Prev Vet Med. [Abstract] [Full-text]
  105. Staphylococcus aureus sinus infections in children.
    Int J Pediatr Otorhinolaryngol. [Abstract] [Full-text]
  106. Post-surgical wound infections involving Enterobacteriaceae with reduced susceptibility to β-lactams in two Portuguese hospitals.
    Int Wound J, 7(6): 508-14. [Abstract] [Full-text]
  107. Efficacy of usual and high doses of daptomycin in combination with rifampin versus alternative therapies in experimental foreign-body infection by methicillin-resistant Staphylococcus aureus.
    Antimicrob Agents Chemother, 54(12): 5251-6. [Abstract] [Full-text]
  108. Novel daptomycin combinations against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus in an in vitro model of simulated endocardial vegetations.
    Antimicrob Agents Chemother, 54(12): 5187-92. [Abstract] [Full-text]
  109. Identification and characterization of the multidrug resistance gene cfr in a Panton-Valentine leukocidin-positive sequence type 8 methicillin-resistant Staphylococcus aureus IVa (USA300) isolate.
    Antimicrob Agents Chemother, 54(12): 4978-84. [Abstract] [Full-text]
  110. In vivo pharmacodynamic activity of tomopenem (formerly CS-023) against Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus in a murine thigh infection model.
    Antimicrob Agents Chemother, 54(12): 5298-302. [Abstract] [Full-text]
  111. Identification of the plasmid-encoded qacA efflux pump gene in meticillin-resistant Staphylococcus aureus (MRSA) strain HPV107, a representative of the MRSA Iberian clone.
    Int J Antimicrob Agents, 36(6): 557-61. [Abstract] [Full-text]
  112. Fusidic acid resistance determinants in Staphylococcus aureus clinical isolates.
    Antimicrob Agents Chemother, 54(12): 4985-91. [Abstract] [Full-text]
  113. Decline in the incidence of healthcare-associated methicillin-resistant Staphylococcus aureus (HA-MRSA) correlates with deceased antimicrobial consumption at a tertiary care hospital in Taiwan, 2001-2009.
    Int J Antimicrob Agents, 36(6): 523-30. [Abstract] [Full-text]
  114. Efficacy of daptomycin combined with rifampicin for the treatment of experimental meticillin-resistant Staphylococcus aureus (MRSA) acute osteomyelitis.
    Int J Antimicrob Agents, 36(6): 542-4. [Abstract] [Full-text]
  115. Comparative efficacies of human simulated exposures of telavancin and vancomycin against methicillin-resistant Staphylococcus aureus with a range of vancomycin MICs in a murine pneumonia model.
    Antimicrob Agents Chemother, 54(12): 5115-9. [Abstract] [Full-text]
  116. Nasal carriage of methicillin-resistant and methicillin-sensitive strains of Staphylococcus sciuri in the Indonesian population.
    Antimicrob Agents Chemother, 54(12): 5413-7. [Abstract] [Full-text]
  117. An RpoB mutation confers dual heteroresistance to daptomycin and vancomycin in Staphylococcus aureus.
    Antimicrob Agents Chemother, 54(12): 5222-33. [Abstract] [Full-text]
  118. Costs of healthcare-associated methicillin-resistant Staphylococcus aureus and its control.
    Clin Microbiol Infect, 16(12): 1721-8. [Abstract] [Full-text]
  119. Molecular picture of community- and healthcare-associated methicillin-resistant Staphylococcus aureus circulating in a teaching hospital in Milan.
    Scand J Infect Dis, 42(11): 873-8. [Abstract] [Full-text]
  120. Cost-effectiveness of adding decolonization to a surveillance strategy of screening and isolation for methicillin-resistant Staphylococcus aureus carriers.
    Clin Microbiol Infect, 16(12): 1740-6. [Abstract] [Full-text]
  121. Risk factors for carbapenem-resistant Acinetobacter baumannii infections at a tertiary care hospital in New Caledonia, South Pacific.
    Scand J Infect Dis, 42(11): 821-6. [Abstract] [Full-text]
  122. Cost-effectiveness of universal MRSA screening on admission to surgery.
    Clin Microbiol Infect, 16(12): 1747-53. [Abstract] [Full-text]
  123. Rapid screening of methicillin-resistant Staphylococcus aureus using PCR and chromogenic agar: a prospective study to evaluate costs and effects.
    Clin Microbiol Infect, 16(12): 1754-61. [Abstract] [Full-text]
  124. Post-surgical wound infections involving Enterobacteriaceae with reduced susceptibility to β-lactams in two Portuguese hospitals.
    Int Wound J, 7(6): 508-14. [Abstract] [Full-text]
  125. Efficacy of usual and high doses of daptomycin in combination with rifampin versus alternative therapies in experimental foreign-body infection by methicillin-resistant Staphylococcus aureus.
    Antimicrob Agents Chemother, 54(12): 5251-6. [Abstract] [Full-text]
  126. Novel daptomycin combinations against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus in an in vitro model of simulated endocardial vegetations.
    Antimicrob Agents Chemother, 54(12): 5187-92. [Abstract] [Full-text]
  127. Identification and characterization of the multidrug resistance gene cfr in a Panton-Valentine leukocidin-positive sequence type 8 methicillin-resistant Staphylococcus aureus IVa (USA300) isolate.
    Antimicrob Agents Chemother, 54(12): 4978-84. [Abstract] [Full-text]
  128. In vivo pharmacodynamic activity of tomopenem (formerly CS-023) against Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus in a murine thigh infection model.
    Antimicrob Agents Chemother, 54(12): 5298-302. [Abstract] [Full-text]
  129. Identification of the plasmid-encoded qacA efflux pump gene in meticillin-resistant Staphylococcus aureus (MRSA) strain HPV107, a representative of the MRSA Iberian clone.
    Int J Antimicrob Agents, 36(6): 557-61. [Abstract] [Full-text]
  130. Fusidic acid resistance determinants in Staphylococcus aureus clinical isolates.
    Antimicrob Agents Chemother, 54(12): 4985-91. [Abstract] [Full-text]
  131. Decline in the incidence of healthcare-associated methicillin-resistant Staphylococcus aureus (HA-MRSA) correlates with deceased antimicrobial consumption at a tertiary care hospital in Taiwan, 2001-2009.
    Int J Antimicrob Agents, 36(6): 523-30. [Abstract] [Full-text]
  132. Efficacy of daptomycin combined with rifampicin for the treatment of experimental meticillin-resistant Staphylococcus aureus (MRSA) acute osteomyelitis.
    Int J Antimicrob Agents, 36(6): 542-4. [Abstract] [Full-text]
  133. Comparative efficacies of human simulated exposures of telavancin and vancomycin against methicillin-resistant Staphylococcus aureus with a range of vancomycin MICs in a murine pneumonia model.
    Antimicrob Agents Chemother, 54(12): 5115-9. [Abstract] [Full-text]
  134. Nasal carriage of methicillin-resistant and methicillin-sensitive strains of Staphylococcus sciuri in the Indonesian population.
    Antimicrob Agents Chemother, 54(12): 5413-7. [Abstract] [Full-text]
  135. An RpoB mutation confers dual heteroresistance to daptomycin and vancomycin in Staphylococcus aureus.
    Antimicrob Agents Chemother, 54(12): 5222-33. [Abstract] [Full-text]
  136. Costs of healthcare-associated methicillin-resistant Staphylococcus aureus and its control.
    Clin Microbiol Infect, 16(12): 1721-8. [Abstract] [Full-text]
  137. Molecular picture of community- and healthcare-associated methicillin-resistant Staphylococcus aureus circulating in a teaching hospital in Milan.
    Scand J Infect Dis, 42(11): 873-8. [Abstract] [Full-text]
  138. Cost-effectiveness of adding decolonization to a surveillance strategy of screening and isolation for methicillin-resistant Staphylococcus aureus carriers.
    Clin Microbiol Infect, 16(12): 1740-6. [Abstract] [Full-text]
  139. Risk factors for carbapenem-resistant Acinetobacter baumannii infections at a tertiary care hospital in New Caledonia, South Pacific.
    Scand J Infect Dis, 42(11): 821-6. [Abstract] [Full-text]
  140. Cost-effectiveness of universal MRSA screening on admission to surgery.
    Clin Microbiol Infect, 16(12): 1747-53. [Abstract] [Full-text]
  141. Rapid screening of methicillin-resistant Staphylococcus aureus using PCR and chromogenic agar: a prospective study to evaluate costs and effects.
    Clin Microbiol Infect, 16(12): 1754-61. [Abstract] [Full-text]
  142. Nursing home-acquired pneumonia: a review of risk factors and therapeutic approaches.
    Curr Med Res Opin, 26(12): 2707-14. [Abstract] [Full-text]
  143. Compliance with hand hygiene in patients with meticillin-resistant Staphylococcus aureus and extended-spectrum β-lactamase-producing enterobacteria.
    J Hosp Infect, 76(4): 320-3. [Abstract] [Full-text]
  144. Costs of nosocomial pneumonia caused by meticillin-resistant Staphylococcus aureus.
    J Hosp Infect, 76(4): 300-3. [Abstract] [Full-text]
  145. The pharmacodynamics of telavancin studied in an in vitro pharmacokinetic model of infection.
    Antimicrob Agents Chemother. [Abstract] [Full-text]
  146. Current pattern of antibiotic resistance in Staphylococcus aureus clinical isolates and the emergence of vancomycin resistance.
    J Coll Physicians Surg Pak, 20(11): 728-32. [Abstract] [Full-text]
  147. Predicting Factors of Plural Hospitalization with Pneumonia in Low Birth Weight Infants.
    Pediatr Int. [Abstract] [Full-text]
  148. Close cooperation between infectious disease physicians and attending physicians can result in better management and outcome for patients with Staphylococcus aureus bacteraemia.
    Clin Microbiol Infect, 16(12): 1783-8. [Abstract] [Full-text]
  149. Real-time PCR assays compared to culture-based approaches for identification of aerobic bacteria in chronic wounds.
    Clin Microbiol Infect, 16(12): 1762-9. [Abstract] [Full-text]
  150. The pharmacodynamics of telavancin studied in an in vitro pharmacokinetic model of infection.
    Antimicrob Agents Chemother. [Abstract] [Full-text]
  151. Predicting Factors of Plural Hospitalization with Pneumonia in Low Birth Weight Infants.
    Pediatr Int. [Abstract] [Full-text]
  152. Close cooperation between infectious disease physicians and attending physicians can result in better management and outcome for patients with Staphylococcus aureus bacteraemia.
    Clin Microbiol Infect, 16(12): 1783-8. [Abstract] [Full-text]
  153. Real-time PCR assays compared to culture-based approaches for identification of aerobic bacteria in chronic wounds.
    Clin Microbiol Infect, 16(12): 1762-9. [Abstract] [Full-text]
  154. Nursing home-acquired pneumonia: a review of risk factors and therapeutic approaches.
    Curr Med Res Opin, 26(12): 2707-14. [Abstract] [Full-text]
  155. Compliance with hand hygiene in patients with meticillin-resistant Staphylococcus aureus and extended-spectrum β-lactamase-producing enterobacteria.
    J Hosp Infect, 76(4): 320-3. [Abstract] [Full-text]
  156. Costs of nosocomial pneumonia caused by meticillin-resistant Staphylococcus aureus.
    J Hosp Infect, 76(4): 300-3. [Abstract] [Full-text]
  157. Preservation of viability and antibacterial activity of Lactobacillus spp. in calcium alginate beads.
    Eur J Pharm Sci, 41(5): 589-96. [Abstract] [Full-text]
  158. Close cooperation between infectious disease physicians and attending physicians can result in better management and outcome for patients with Staphylococcus aureus bacteraemia.
    Clin Microbiol Infect, 16(12): 1783-8. [Abstract] [Full-text]
  159. Real-time PCR assays compared to culture-based approaches for identification of aerobic bacteria in chronic wounds.
    Clin Microbiol Infect, 16(12): 1762-9. [Abstract] [Full-text]
  160. Nursing home-acquired pneumonia: a review of risk factors and therapeutic approaches.
    Curr Med Res Opin, 26(12): 2707-14. [Abstract] [Full-text]
  161. Compliance with hand hygiene in patients with meticillin-resistant Staphylococcus aureus and extended-spectrum β-lactamase-producing enterobacteria.
    J Hosp Infect, 76(4): 320-3. [Abstract] [Full-text]
  162. Costs of nosocomial pneumonia caused by meticillin-resistant Staphylococcus aureus.
    J Hosp Infect, 76(4): 300-3. [Abstract] [Full-text]
  163. Preservation of viability and antibacterial activity of Lactobacillus spp. in calcium alginate beads.
    Eur J Pharm Sci, 41(5): 589-96. [Abstract] [Full-text]
  164. Preservation of viability and antibacterial activity of Lactobacillus spp. in calcium alginate beads.
    Eur J Pharm Sci, 41(5): 589-96. [Abstract] [Full-text]
  165. MRSA screening on a paediatric intensive care unit.
    Arch Dis Child. [Abstract] [Full-text]
  166. ATLAS trials: efficacy and safety of telavancin compared with vancomycin for the treatment of skin infections.
    Future Microbiol. [Abstract] [Full-text]
  167. MRSA screening on a paediatric intensive care unit.
    Arch Dis Child. [Abstract] [Full-text]
  168. Livestock associated methicillin-resistant Staphylococcus aureus (LaMRSA) isolated from lesions of pigs at necropsy in northwest Germany between 2004 and 2007.
    Zoonoses Public Health, 57(7): e143-8. [Abstract] [Full-text]
  169. Rapid differentiation of Staphylococcus aureus, Staphylococcus epidermidis and other coagulase-negative staphylococci and meticillin susceptibility testing directly from growth-positive blood cultures by multiplex real-time PCR.
    J Med Microbiol, 59: 1456-61. [Abstract] [Full-text]
  170. Invasive community-associated MRSA infections: epidemiology and antimicrobial management.
    Expert Opin Pharmacother, 11(18): 3009-25. [Abstract] [Full-text]
  171. Effectiveness of a Guideline to Reduce Vancomycin Use in the Neonatal Intensive Care Unit.
    Pediatr Infect Dis J. [Abstract] [Full-text]
  172. Methicillin-Resistant Staphylococcus aureus: A Community Health Threat.
    Postgrad Med, 122(6): 16-23. [Abstract] [Full-text]
  173. Association of High-Level Mupirocin Resistance and Multi-Drug Resistant Methicillin-Resistant Staphylococcus aureus at an Academic Center in the Midwestern United States.
    J Clin Microbiol. [Abstract] [Full-text]
  174. Factors associated with nasal colonization of methicillin-resistant Staphylococcus aureus among healthy children in Taiwan.
    J Clin Microbiol. [Abstract] [Full-text]
  175. Review of resistance of ocular isolates of Pseudomonas aeruginosa and staphylococci from keratitis to ciprofloxacin, gentamicin and cephalosporins.
    Clin Exp Optom. [Abstract] [Full-text]
  176. Comparative analysis of virulence and toxin expression of global community-associated methicillin-resistant Staphylococcus aureus strains.
    J Infect Dis, 202(12): 1866-76. [Abstract] [Full-text]
  177. Effectiveness of a Guideline to Reduce Vancomycin Use in the Neonatal Intensive Care Unit.
    Pediatr Infect Dis J. [Abstract] [Full-text]
  178. Association of High-Level Mupirocin Resistance and Multi-Drug Resistant Methicillin-Resistant Staphylococcus aureus at an Academic Center in the Midwestern United States.
    J Clin Microbiol. [Abstract] [Full-text]
  179. Factors associated with nasal colonization of methicillin-resistant Staphylococcus aureus among healthy children in Taiwan.
    J Clin Microbiol. [Abstract] [Full-text]
  180. Review of resistance of ocular isolates of Pseudomonas aeruginosa and staphylococci from keratitis to ciprofloxacin, gentamicin and cephalosporins.
    Clin Exp Optom. [Abstract] [Full-text]
  181. Comparative analysis of virulence and toxin expression of global community-associated methicillin-resistant Staphylococcus aureus strains.
    J Infect Dis, 202(12): 1866-76. [Abstract] [Full-text]
  182. Invasive community-associated MRSA infections: epidemiology and antimicrobial management.
    Expert Opin Pharmacother, 11(18): 3009-25. [Abstract] [Full-text]
  183. Rapid differentiation of Staphylococcus aureus, Staphylococcus epidermidis and other coagulase-negative staphylococci and meticillin susceptibility testing directly from growth-positive blood cultures by multiplex real-time PCR.
    J Med Microbiol, 59: 1456-61. [Abstract] [Full-text]
  184. Livestock associated methicillin-resistant Staphylococcus aureus (LaMRSA) isolated from lesions of pigs at necropsy in northwest Germany between 2004 and 2007.
    Zoonoses Public Health, 57(7): e143-8. [Abstract] [Full-text]
  185. Comparative analysis of virulence and toxin expression of global community-associated methicillin-resistant Staphylococcus aureus strains.
    J Infect Dis, 202(12): 1866-76. [Abstract] [Full-text]
  186. Invasive community-associated MRSA infections: epidemiology and antimicrobial management.
    Expert Opin Pharmacother, 11(18): 3009-25. [Abstract] [Full-text]
  187. Eradication of drug resistant Staphylococcus aureus by liposomal oleic acids.
    Biomaterials, 32(1): 214-21. [Abstract] [Full-text]
  188. Rapid differentiation of Staphylococcus aureus, Staphylococcus epidermidis and other coagulase-negative staphylococci and meticillin susceptibility testing directly from growth-positive blood cultures by multiplex real-time PCR.
    J Med Microbiol, 59: 1456-61. [Abstract] [Full-text]
  189. Livestock associated methicillin-resistant Staphylococcus aureus (LaMRSA) isolated from lesions of pigs at necropsy in northwest Germany between 2004 and 2007.
    Zoonoses Public Health, 57(7): e143-8. [Abstract] [Full-text]
  190. Comparative analysis of virulence and toxin expression of global community-associated methicillin-resistant Staphylococcus aureus strains.
    J Infect Dis, 202(12): 1866-76. [Abstract] [Full-text]
  191. Eradication of drug resistant Staphylococcus aureus by liposomal oleic acids.
    Biomaterials, 32(1): 214-21. [Abstract] [Full-text]
  192. Eradication of drug resistant Staphylococcus aureus by liposomal oleic acids.
    Biomaterials, 32(1): 214-21. [Abstract] [Full-text]
  193. In vitro antibacterial activity of doripenem against clinical isolates from French teaching hospitals: proposition of zone diameter breakpoints.
    Eur J Clin Microbiol Infect Dis. [Abstract] [Full-text]
  194. In vitro Activity of Dalbavancin against Staphylococci Isolated in Istanbul, Turkey.
    Chemotherapy, 56(6): 444-447. [Abstract] [Full-text]
  195. In vitro antibacterial activity of doripenem against clinical isolates from French teaching hospitals: proposition of zone diameter breakpoints.
    Eur J Clin Microbiol Infect Dis. [Abstract] [Full-text]
  196. Identification of two borderline oxacillin-resistant strains of Staphylococcus aureus from routine nares swab specimens by one of three chromogenic agars evaluated for the detection of MRSA.
    Am J Clin Pathol, 134(6): 921-7. [Abstract] [Full-text]
  197. Identification of two borderline oxacillin-resistant strains of Staphylococcus aureus from routine nares swab specimens by one of three chromogenic agars evaluated for the detection of MRSA.
    Am J Clin Pathol, 134(6): 921-7. [Abstract] [Full-text]
  198. Identification of two borderline oxacillin-resistant strains of Staphylococcus aureus from routine nares swab specimens by one of three chromogenic agars evaluated for the detection of MRSA.
    Am J Clin Pathol, 134(6): 921-7. [Abstract] [Full-text]
  199. Effect of Momordica charantia L. in the resistance to aminoglycosides in methicilin-resistant Staphylococcus aureus.
    Comp Immunol Microbiol Infect Dis, 33(6): 467-71. [Abstract] [Full-text]
  200. A matched prospective cohort study on Staphylococcus aureus and Escherichia coli bloodstream infections: Extended perspectives beyond resistance.
    Am J Infect Control, 38(10): 839-45. [Abstract] [Full-text]
  201. Vancomycin release from poly(d,l-lactic acid) spray-coated hydroxyapatite fibers.
    Eur J Pharm Biopharm, 76(3): 366-70. [Abstract] [Full-text]
  202. Community acquired methicillin resistant Staphylococcus aureus: a rare presentation.
    Indian J Pediatr, 77(11): 1332-4. [Abstract] [Full-text]
  203. Impact of Staphylococcus aureus on the pathogenesis of chronic cystic fibrosis lung disease.
    Int J Med Microbiol, 300(8): 514-9. [Abstract] [Full-text]
  204. Efficacy of concurrent application of chlorhexidine gluconate and povidone iodine against six nosocomial pathogens.
    Am J Infect Control, 38(10): 826-31. [Abstract] [Full-text]
  205. Prevalence of MRSA in elective day case pediatric ENT surgical patients.
    Int J Pediatr Otorhinolaryngol, 74(12): 1430-1. [Abstract] [Full-text]
  206. The synthesis of phenylalanine-derived C5-substituted rhodanines and their activity against selected methicillin-resistant Staphylococcus aureus (MRSA) strains.
    Eur J Med Chem, 45(12): 5827-32. [Abstract] [Full-text]
  207. The dissemination of ST80-SCCmec-IV community-associated methicillin resistant Staphylococcus aureus clone in Kuwait hospitals.
    Ann Clin Microbiol Antimicrob, 9: 31. [Abstract] [Full-text]
  208. Characterization of a New SCCmec Element in Staphylococcus cohnii.
    PLoS One, 5(11): e14016. [Abstract] [Full-text]
  209. Characterisation of Australian MRSA Strains ST75- and ST883-MRSA-IV and Analysis of Their Accessory Gene Regulator Locus.
    PLoS One, 5(11): e14025. [Abstract] [Full-text]
  210. Increased Incidence of Sacroiliac Joint Infection At a Children's Hospital.
    J Pediatr Orthop, 30(8): 893-8. [Abstract] [Full-text]
  211. Secular Trends in Antibiotic Use Among Neonates: 2001-2008.
    Pediatr Infect Dis J. [Abstract] [Full-text]
  212. Subconjunctival Injections and Povidone-Iodine Washings for the Treatment of Giant Fornix Syndrome.
    Cornea. [Abstract] [Full-text]
  213. Surveillance of Antimicrobial Susceptibility among Bacterial Isolates from Intensive Care Unit Patients of a Tertiary-Care University Hospital in Iran: 2006-2009.
    Chemotherapy, 56(6): 478-484. [Abstract] [Full-text]
  214. Mortality associated with in-hospital bacteraemia caused by Staphylococcus aureus: a multistate analysis with follow-up beyond hospital discharge.
    J Antimicrob Chemother. [Abstract] [Full-text]
  215. In Vitro Antimicrobial Activity of Wall Teichoic Acid Biosynthesis Inhibitors against Staphylococcus aureus Isolates.
    Antimicrob Agents Chemother. [Abstract] [Full-text]
  216. Efficacy of Fosfomycin in Experimental Osteomyelitis Due to Methicillin-Resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. [Abstract] [Full-text]
  217. A Novel Chimeric Lysin shows superiority to Mupirocin for Skin Decolonization of Antibiotic Resistant (MRSA) and Sensitive (MSSA) Staphylococcus aureus.
    Antimicrob Agents Chemother. [Abstract] [Full-text]
  218. Combinatorial Phenotypic Signatures Distinguish Persistent from Resolving Methicillin-Resistant Staphylococcus aureus Bacteremia Isolates.
    Antimicrob Agents Chemother. [Abstract] [Full-text]
  219. Methicillin-resistant Staphylococcus aureus (MRSA) in pork production shower facilities.
    Appl Environ Microbiol. [Abstract] [Full-text]
  220. Forced-air warming blowers: An evaluation of filtration adequacy and airborne contamination emissions in the operating room.
    Am J Infect Control. [Abstract] [Full-text]
  221. Drainage Surgery Followed by Postoperative Irrigation with Gentian Violet for Prosthetic Graft Infection Caused by Methicillin-resistant Staphylococcus aureus.
    Eur J Vasc Endovasc Surg. [Abstract] [Full-text]
  222. Variations in spa types found in consecutive MRSA isolates from the same patients.
    FEMS Microbiol Lett. [Abstract] [Full-text]
  223. Nitropyrrolins A-E, Cytotoxic Farnesyl-α-nitropyrroles from a Marine-Derived Bacterium within the Actinomycete Family Streptomycetaceae.
    J Nat Prod. [Abstract] [Full-text]
  224. Induced Production of Bromomethylchlamydosporols A and B from the Marine-Derived Fungus Fusarium tricinctum.
    J Nat Prod. [Abstract] [Full-text]
  225. Characterization of a new SCCmec element in Staphylococcus cohnii.
    PLoS One, 5(11): e14016. [Abstract] [Full-text]
  226. Characterisation of Australian MRSA strains ST75- and ST883-MRSA-IV and analysis of their accessory gene regulator locus.
    PLoS One, 5(11): e14025. [Abstract] [Full-text]
  227. Increased incidence of sacroiliac joint infection at a children's hospital.
    J Pediatr Orthop, 30(8): 893-8. [Abstract] [Full-text]
  228. Secular Trends in Antibiotic Use Among Neonates: 2001-2008.
    Pediatr Infect Dis J. [Abstract] [Full-text]
  229. Subconjunctival Injections and Povidone-Iodine Washings for the Treatment of Giant Fornix Syndrome.
    Cornea. [Abstract] [Full-text]
  230. Mortality associated with in-hospital bacteraemia caused by Staphylococcus aureus: a multistate analysis with follow-up beyond hospital discharge.
    J Antimicrob Chemother. [Abstract] [Full-text]
  231. In Vitro Antimicrobial Activity of Wall Teichoic Acid Biosynthesis Inhibitors against Staphylococcus aureus Isolates.
    Antimicrob Agents Chemother. [Abstract] [Full-text]
  232. Efficacy of Fosfomycin in Experimental Osteomyelitis Due to Methicillin-Resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. [Abstract] [Full-text]
  233. A Novel Chimeric Lysin shows superiority to Mupirocin for Skin Decolonization of Antibiotic Resistant (MRSA) and Sensitive (MSSA) Staphylococcus aureus.
    Antimicrob Agents Chemother. [Abstract] [Full-text]
  234. Combinatorial Phenotypic Signatures Distinguish Persistent from Resolving Methicillin-Resistant Staphylococcus aureus Bacteremia Isolates.
    Antimicrob Agents Chemother. [Abstract] [Full-text]
  235. Methicillin-resistant Staphylococcus aureus (MRSA) in pork production shower facilities.
    Appl Environ Microbiol. [Abstract] [Full-text]
  236. Forced-air warming blowers: An evaluation of filtration adequacy and airborne contamination emissions in the operating room.
    Am J Infect Control. [Abstract] [Full-text]
  237. Drainage Surgery Followed by Postoperative Irrigation with Gentian Violet for Prosthetic Graft Infection Caused by Methicillin-resistant Staphylococcus aureus.
    Eur J Vasc Endovasc Surg. [Abstract] [Full-text]
  238. Nitropyrrolins A-E, Cytotoxic Farnesyl-α-nitropyrroles from a Marine-Derived Bacterium within the Actinomycete Family Streptomycetaceae.
    J Nat Prod. [Abstract] [Full-text]
  239. Induced Production of Bromomethylchlamydosporols A and B from the Marine-Derived Fungus Fusarium tricinctum.
    J Nat Prod. [Abstract] [Full-text]
  240. The dissemination of ST80-SCCmec-IV community-associated methicillin resistant Staphylococcus aureus clone in Kuwait hospitals.
    Ann Clin Microbiol Antimicrob, 9: 31. [Abstract] [Full-text]
  241. Efficacy of concurrent application of chlorhexidine gluconate and povidone iodine against six nosocomial pathogens.
    Am J Infect Control, 38(10): 826-31. [Abstract] [Full-text]
  242. Prevalence of MRSA in elective day case pediatric ENT surgical patients.
    Int J Pediatr Otorhinolaryngol, 74(12): 1430-1. [Abstract] [Full-text]
  243. The synthesis of phenylalanine-derived C5-substituted rhodanines and their activity against selected methicillin-resistant Staphylococcus aureus (MRSA) strains.
    Eur J Med Chem, 45(12): 5827-32. [Abstract] [Full-text]
  244. Impact of Staphylococcus aureus on the pathogenesis of chronic cystic fibrosis lung disease.
    Int J Med Microbiol, 300(8): 514-9. [Abstract] [Full-text]
  245. A matched prospective cohort study on Staphylococcus aureus and Escherichia coli bloodstream infections: extended perspectives beyond resistance.
    Am J Infect Control, 38(10): 839-45. [Abstract] [Full-text]
  246. Effect of Momordica charantia L. in the resistance to aminoglycosides in methicilin-resistant Staphylococcus aureus.
    Comp Immunol Microbiol Infect Dis, 33(6): 467-71. [Abstract] [Full-text]
  247. Increased incidence of sacroiliac joint infection at a children's hospital.
    J Pediatr Orthop, 30(8): 893-8. [Abstract] [Full-text]
  248. Effectiveness of gentian violet and similar products commonly used to treat pyodermas.
    Dermatol Clin, 29(1): 69-73. [Abstract] [Full-text]
  249. Community-associated methicillin-resistant Staphylococcus aureus skin infections in the tropics.
    Dermatol Clin, 29(1): 21-32. [Abstract] [Full-text]
  250. Efficacy of concurrent application of chlorhexidine gluconate and povidone iodine against six nosocomial pathogens.
    Am J Infect Control, 38(10): 826-31. [Abstract] [Full-text]
  251. Prevalence of MRSA in elective day case pediatric ENT surgical patients.
    Int J Pediatr Otorhinolaryngol, 74(12): 1430-1. [Abstract] [Full-text]
  252. The synthesis of phenylalanine-derived C5-substituted rhodanines and their activity against selected methicillin-resistant Staphylococcus aureus (MRSA) strains.
    Eur J Med Chem, 45(12): 5827-32. [Abstract] [Full-text]
  253. Impact of Staphylococcus aureus on the pathogenesis of chronic cystic fibrosis lung disease.
    Int J Med Microbiol, 300(8): 514-9. [Abstract] [Full-text]
  254. A matched prospective cohort study on Staphylococcus aureus and Escherichia coli bloodstream infections: extended perspectives beyond resistance.
    Am J Infect Control, 38(10): 839-45. [Abstract] [Full-text]
  255. Effect of Momordica charantia L. in the resistance to aminoglycosides in methicilin-resistant Staphylococcus aureus.
    Comp Immunol Microbiol Infect Dis, 33(6): 467-71. [Abstract] [Full-text]
  256. Effectiveness of gentian violet and similar products commonly used to treat pyodermas.
    Dermatol Clin, 29(1): 69-73. [Abstract] [Full-text]
  257. Community-associated methicillin-resistant Staphylococcus aureus skin infections in the tropics.
    Dermatol Clin, 29(1): 21-32. [Abstract] [Full-text]
  258. Effectiveness of gentian violet and similar products commonly used to treat pyodermas.
    Dermatol Clin, 29(1): 69-73. [Abstract] [Full-text]
  259. Community-associated methicillin-resistant Staphylococcus aureus skin infections in the tropics.
    Dermatol Clin, 29(1): 21-32. [Abstract] [Full-text]
  260. Molecular and epidemiological analysis of methicillin-resistant Staphylococcus aureus otorrhoea: hospital- or community-acquired?
    J Laryngol Otol, 124(12): 1247-50. [Abstract] [Full-text]
  261. DISTINCT BACTERIOPHAGES ENCODING PVL AMONG INTERNATIONAL CLONES OF PVL-MRSA.
    J Clin Microbiol. [Abstract] [Full-text]
  262. Ventilator-associated pneumonia in critically ill stroke patients: Frequency, risk factors, and outcomes.
    J Crit Care. [Abstract] [Full-text]
  263. DISTINCT BACTERIOPHAGES ENCODING PVL AMONG INTERNATIONAL CLONES OF PVL-MRSA.
    J Clin Microbiol. [Abstract] [Full-text]
  264. Ventilator-associated pneumonia in critically ill stroke patients: Frequency, risk factors, and outcomes.
    J Crit Care. [Abstract] [Full-text]
  265. Molecular and epidemiological analysis of methicillin-resistant Staphylococcus aureus otorrhoea: hospital- or community-acquired?
    J Laryngol Otol, 124(12): 1247-50. [Abstract] [Full-text]
  266. Molecular and epidemiological analysis of methicillin-resistant Staphylococcus aureus otorrhoea: hospital- or community-acquired?
    J Laryngol Otol, 124(12): 1247-50. [Abstract] [Full-text]
  267. In vitro activity of two old antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus.
    J Antibiot (Tokyo), 63(11): 657-9. [Abstract] [Full-text]
  268. Real-time evaluation of an optimised real-time PCR assay for the detection of Methicillin-Resistant Staphylococcus aureus (MRSA) Versus Brilliance Chromogenic MRSA agar from clinical specimens.
    J Med Microbiol. [Abstract] [Full-text]
  269. Challenging and emerging pathogens in cystic fibrosis.
    Paediatr Respir Rev, 11(4): 246-54. [Abstract] [Full-text]
  270. Measuring the externality of antibacterial use from promoting antimicrobial resistance.
    Pharmacoeconomics, 28(12): 1123-8. [Abstract] [Full-text]
  271. Real-time evaluation of an optimised real-time PCR assay for the detection of Methicillin-Resistant Staphylococcus aureus (MRSA) Versus Brilliance Chromogenic MRSA agar from clinical specimens.
    J Med Microbiol. [Abstract] [Full-text]
  272. Challenging and emerging pathogens in cystic fibrosis.
    Paediatr Respir Rev, 11(4): 246-54. [Abstract] [Full-text]
  273. Measuring the externality of antibacterial use from promoting antimicrobial resistance.
    Pharmacoeconomics, 28(12): 1123-8. [Abstract] [Full-text]
  274. Real-time evaluation of an optimised real-time PCR assay for the detection of Methicillin-Resistant Staphylococcus aureus (MRSA) Versus Brilliance Chromogenic MRSA agar from clinical specimens.
    J Med Microbiol. [Abstract] [Full-text]
  275. Challenging and emerging pathogens in cystic fibrosis.
    Paediatr Respir Rev, 11(4): 246-54. [Abstract] [Full-text]
  276. Measuring the externality of antibacterial use from promoting antimicrobial resistance.
    Pharmacoeconomics, 28(12): 1123-8. [Abstract] [Full-text]
  277. An unnatural history of left ventricular pseudoaneurysm?
    J Am Soc Echocardiogr, 23(12): 1335.e5-7. [Abstract] [Full-text]
  278. Highly Brominated Antimicrobial Metabolites from a Marine Pseudoalteromonas sp.
    J Nat Prod, 73(11): 1963-1966. [Abstract] [Full-text]
  279. High-throughput identification of antibacterials against methicillin-resistant Staphylococcus aureus (MRSA) and the transglycosylase.
    Bioorg Med Chem, 18(24): 8512-29. [Abstract] [Full-text]
  280. Epidemiology of bacteraemia in Hamad general hospital, Qatar: A one year hospital-based study.
    Travel Med Infect Dis, 8(6): 377-87. [Abstract] [Full-text]
  281. Prevalence and acquisition of MRSA amongst patients admitted to a tertiary-care hospital in brazil.
    BMC Infect Dis, 10: 328. [Abstract] [Full-text]
  282. Bayesian phylogenetics of bacterial genomes: inferring the pandemic spread of Methicillin resistant Staphylococcus aureus ST239.
    Mol Biol Evol. [Abstract] [Full-text]
  283. Synthesis and antibacterial activity study of a novel class of cationic anthraquinone analogs.
    Bioorg Med Chem. [Abstract] [Full-text]
  284. Immunoglobulin A-dominant postinfectious glomerulonephritis: frequent occurrence in nondiabetic patients with Staphylococcus aureus infection.
    Hum Pathol. [Abstract] [Full-text]
  285. Penetration and effectiveness of prophylactic fluoroquinolones in experimental methicillin-sensitive or methicillin-resistant Staphylococcus aureus anterior chamber infections.
    J Cataract Refract Surg, 36(12): 2160-7. [Abstract] [Full-text]
  286. Synthesis and antibacterial activity study of a novel class of cationic anthraquinone analogs.
    Bioorg Med Chem. [Abstract] [Full-text]
  287. Immunoglobulin A-dominant postinfectious glomerulonephritis: frequent occurrence in nondiabetic patients with Staphylococcus aureus infection.
    Hum Pathol. [Abstract] [Full-text]
  288. Penetration and effectiveness of prophylactic fluoroquinolones in experimental methicillin-sensitive or methicillin-resistant Staphylococcus aureus anterior chamber infections.
    J Cataract Refract Surg, 36(12): 2160-7. [Abstract] [Full-text]
  289. High-throughput identification of antibacterials against methicillin-resistant Staphylococcus aureus (MRSA) and the transglycosylase.
    Bioorg Med Chem, 18(24): 8512-29. [Abstract] [Full-text]
  290. Epidemiology of bacteraemia in Hamad general hospital, Qatar: a one year hospital-based study.
    Travel Med Infect Dis, 8(6): 377-87. [Abstract] [Full-text]
  291. Prevalence and acquisition of MRSA amongst patients admitted to a tertiary-care hospital in Brazil.
    BMC Infect Dis, 10: 328. [Abstract] [Full-text]
  292. Highly brominated antimicrobial metabolites from a marine Pseudoalteromonas sp.
    J Nat Prod, 73(11): 1963-6. [Abstract] [Full-text]
  293. An unnatural history of left ventricular pseudoaneurysm?
    J Am Soc Echocardiogr, 23(12): 1335.e5-7. [Abstract] [Full-text]
  294. Immunoglobulin A-dominant postinfectious glomerulonephritis: frequent occurrence in nondiabetic patients with Staphylococcus aureus infection.
    Hum Pathol. [Abstract] [Full-text]
  295. Penetration and effectiveness of prophylactic fluoroquinolones in experimental methicillin-sensitive or methicillin-resistant Staphylococcus aureus anterior chamber infections.
    J Cataract Refract Surg, 36(12): 2160-7. [Abstract] [Full-text]
  296. High-throughput identification of antibacterials against methicillin-resistant Staphylococcus aureus (MRSA) and the transglycosylase.
    Bioorg Med Chem, 18(24): 8512-29. [Abstract] [Full-text]
  297. Use of experimental design for the optimization of the production of new secondary metabolites by two Penicillium species.
    J Nat Prod, 73(11): 1821-32. [Abstract] [Full-text]
  298. Phytochemical investigations of Stemona curtisii and synthetic studies on stemocurtisine alkaloids.
    J Nat Prod, 73(11): 1833-8. [Abstract] [Full-text]
  299. Highly brominated antimicrobial metabolites from a marine Pseudoalteromonas sp.
    J Nat Prod, 73(11): 1963-6. [Abstract] [Full-text]
  300. An unnatural history of left ventricular pseudoaneurysm?
    J Am Soc Echocardiogr, 23(12): 1335.e5-7. [Abstract] [Full-text]
  301. High-throughput identification of antibacterials against methicillin-resistant Staphylococcus aureus (MRSA) and the transglycosylase.
    Bioorg Med Chem, 18(24): 8512-29. [Abstract] [Full-text]
  302. Identification of β-lactamases in human and bovine isolates of Staphylococcus aureus strains having borderline resistance to penicillinase-resistant penicillins (PRPs) with proteomic methods.
    Vet Microbiol, 147(1): 96-102. [Abstract] [Full-text]
  303. Identification of β-lactamases in human and bovine isolates of Staphylococcus aureus strains having borderline resistance to penicillinase-resistant penicillins (PRPs) with proteomic methods.
    Vet Microbiol, 147(1): 96-102. [Abstract] [Full-text]
  304. Identification of β-lactamases in human and bovine isolates of Staphylococcus aureus strains having borderline resistance to penicillinase-resistant penicillins (PRPs) with proteomic methods.
    Vet Microbiol, 147(1): 96-102. [Abstract] [Full-text]
  305. The in vitro evaluation of solithromycin (CEM-101) against pathogens isolated in the United States and Europe (2009).
    J Infect, 61(6): 476-83. [Abstract] [Full-text]
  306. Risk factors for mortality of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infection: With investigation of the potential role of community-associated MRSA strains.
    J Infect, 61(6): 449-57. [Abstract] [Full-text]
  307. Incidence of and Risk Factors for Community-Associated Methicillin-Resistant Staphylococcus aureus Acquired Infection or Colonization in Intensive-Care-Unit Patients.
    J Clin Microbiol, 48(12): 4439-44. [Abstract] [Full-text]
  308. Reliability of the BD GeneOhm Methicillin-Resistant Staphylococcus aureus (MRSA) Assay in Detecting MRSA Isolates with a Variety of Genotypes from the United States and Taiwan.
    J Clin Microbiol, 48(12): 4546-51. [Abstract] [Full-text]
  309. Molecular Characterization of Clinical Methicillin-Resistant Staphylococcus aureus Isolates in South Africa.
    J Clin Microbiol, 48(12): 4608-11. [Abstract] [Full-text]
  310. Evaluation of the BD GeneOhm Assay Using the Rotor-Gene 6000 Platform for Rapid Detection of Methicillin-Resistant Staphylococcus aureus from Pooled Screening Swabs.
    J Clin Microbiol, 48(12): 4559-62. [Abstract] [Full-text]
  311. Evaluation of Molecular Assays for Rapid Detection of Methicillin-Resistant Staphylococcus aureus.
    J Clin Microbiol, 48(12): 4598-4601. [Abstract] [Full-text]
  312. Complete Nucleotide Sequence Analysis of Plasmids in Strains of Staphylococcus aureus Clone USA300 Reveals a High Level of Identity among Isolates with Closely Related Core Genome Sequences.
    J Clin Microbiol, 48(12): 4504-11. [Abstract] [Full-text]
  313. Green synthesis of silver/montmorillonite/chitosan bionanocomposites using the UV irradiation method and evaluation of antibacterial activity.
    Int J Nanomedicine, 5: 875-87. [Abstract] [Full-text]
  314. A Phase 2 Randomized, Double-Blind, Dose-Ranging Study Evaluating the Safety, Tolerability, Population Pharmacokinetics, and Efficacy of Oral Torezolid Phosphate in Patients with Complicated Skin and Skin Structure Infections (cSSSI).
    Antimicrob Agents Chemother. [Abstract] [Full-text]
  315. Influence of ciprofloxacin and vancomycin on mutation rate and transposition of IS256 in Staphylococcus aureus.
    Int J Med Microbiol. [Abstract] [Full-text]
  316. Photodynamic inactivation of multi-resistant bacteria (PIB) - a new approach to treat superficial infections in the 21(st) century.
    J Dtsch Dermatol Ges. [Abstract] [Full-text]
  317. Presence of adequate intravitreal concentrations of daptomycin after systemic intravenous administration in a patient with endogenous endophthalmitis.
    Pharmacotherapy, 30(12): 1247-51. [Abstract] [Full-text]
  318. A Phase 2 Randomized, Double-Blind, Dose-Ranging Study Evaluating the Safety, Tolerability, Population Pharmacokinetics, and Efficacy of Oral Torezolid Phosphate in Patients with Complicated Skin and Skin Structure Infections (cSSSI).
    Antimicrob Agents Chemother. [Abstract] [Full-text]
  319. Influence of ciprofloxacin and vancomycin on mutation rate and transposition of IS256 in Staphylococcus aureus.
    Int J Med Microbiol. [Abstract] [Full-text]
  320. Photodynamic inactivation of multi-resistant bacteria (PIB) - a new approach to treat superficial infections in the 21(st) century.
    J Dtsch Dermatol Ges. [Abstract] [Full-text]
  321. Presence of adequate intravitreal concentrations of daptomycin after systemic intravenous administration in a patient with endogenous endophthalmitis.
    Pharmacotherapy, 30(12): 1247-51. [Abstract] [Full-text]
  322. Evaluation of the BD GeneOhm assay using the rotor-gene 6000 platform for rapid detection of methicillin-resistant Staphylococcus aureus from pooled screening swabs.
    J Clin Microbiol, 48(12): 4559-62. [Abstract] [Full-text]
  323. Evaluation of molecular assays for rapid detection of methicillin-resistant Staphylococcus aureus.
    J Clin Microbiol, 48(12): 4598-601. [Abstract] [Full-text]
  324. Complete nucleotide sequence analysis of plasmids in strains of Staphylococcus aureus clone USA300 reveals a high level of identity among isolates with closely related core genome sequences.
    J Clin Microbiol, 48(12): 4504-11. [Abstract] [Full-text]
  325. Incidence of and risk factors for community-associated methicillin-resistant Staphylococcus aureus acquired infection or colonization in intensive-care-unit patients.
    J Clin Microbiol, 48(12): 4439-44. [Abstract] [Full-text]
  326. Reliability of the BD GeneOhm methicillin-resistant Staphylococcus aureus (MRSA) assay in detecting MRSA isolates with a variety of genotypes from the United States and Taiwan.
    J Clin Microbiol, 48(12): 4546-51. [Abstract] [Full-text]
  327. Molecular characterization of clinical methicillin-resistant Staphylococcus aureus isolates in South Africa.
    J Clin Microbiol, 48(12): 4608-11. [Abstract] [Full-text]
  328. Risk factors for mortality of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infection: with investigation of the potential role of community-associated MRSA strains.
    J Infect, 61(6): 449-57. [Abstract] [Full-text]
  329. The in vitro evaluation of solithromycin (CEM-101) against pathogens isolated in the United States and Europe (2009).
    J Infect, 61(6): 476-83. [Abstract] [Full-text]
  330. A Phase 2 Randomized, Double-Blind, Dose-Ranging Study Evaluating the Safety, Tolerability, Population Pharmacokinetics, and Efficacy of Oral Torezolid Phosphate in Patients with Complicated Skin and Skin Structure Infections (cSSSI).
    Antimicrob Agents Chemother. [Abstract] [Full-text]
  331. Photodynamic inactivation of multi-resistant bacteria (PIB) - a new approach to treat superficial infections in the 21(st) century.
    J Dtsch Dermatol Ges. [Abstract] [Full-text]
  332. Presence of adequate intravitreal concentrations of daptomycin after systemic intravenous administration in a patient with endogenous endophthalmitis.
    Pharmacotherapy, 30(12): 1247-51. [Abstract] [Full-text]
  333. Evaluation of the BD GeneOhm assay using the rotor-gene 6000 platform for rapid detection of methicillin-resistant Staphylococcus aureus from pooled screening swabs.
    J Clin Microbiol, 48(12): 4559-62. [Abstract] [Full-text]
  334. Evaluation of molecular assays for rapid detection of methicillin-resistant Staphylococcus aureus.
    J Clin Microbiol, 48(12): 4598-601. [Abstract] [Full-text]
  335. Complete nucleotide sequence analysis of plasmids in strains of Staphylococcus aureus clone USA300 reveals a high level of identity among isolates with closely related core genome sequences.
    J Clin Microbiol, 48(12): 4504-11. [Abstract] [Full-text]
  336. Incidence of and risk factors for community-associated methicillin-resistant Staphylococcus aureus acquired infection or colonization in intensive-care-unit patients.
    J Clin Microbiol, 48(12): 4439-44. [Abstract] [Full-text]
  337. Reliability of the BD GeneOhm methicillin-resistant Staphylococcus aureus (MRSA) assay in detecting MRSA isolates with a variety of genotypes from the United States and Taiwan.
    J Clin Microbiol, 48(12): 4546-51. [Abstract] [Full-text]
  338. Molecular characterization of clinical methicillin-resistant Staphylococcus aureus isolates in South Africa.
    J Clin Microbiol, 48(12): 4608-11. [Abstract] [Full-text]
  339. Risk factors for mortality of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infection: with investigation of the potential role of community-associated MRSA strains.
    J Infect, 61(6): 449-57. [Abstract] [Full-text]
  340. The in vitro evaluation of solithromycin (CEM-101) against pathogens isolated in the United States and Europe (2009).
    J Infect, 61(6): 476-83. [Abstract] [Full-text]
  341. MALDI-TOF MS fingerprinting allows for discrimination of major methicillin-resistant Staphylococcus aureus lineages.
    Int J Med Microbiol, 301(1): 64-8. [Abstract] [Full-text]
  342. The matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry (MALDI-TOF MS)-based protein peaks of 4448 and 5302 Da are not associated with the presence of Panton-Valentine leukocidin.
    Int J Med Microbiol, 301(1): 58-63. [Abstract] [Full-text]
  343. MALDI-TOF MS fingerprinting allows for discrimination of major methicillin-resistant Staphylococcus aureus lineages.
    Int J Med Microbiol, 301(1): 64-8. [Abstract] [Full-text]
  344. The matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry (MALDI-TOF MS)-based protein peaks of 4448 and 5302 Da are not associated with the presence of Panton-Valentine leukocidin.
    Int J Med Microbiol, 301(1): 58-63. [Abstract] [Full-text]
  345. MALDI-TOF MS fingerprinting allows for discrimination of major methicillin-resistant Staphylococcus aureus lineages.
    Int J Med Microbiol, 301(1): 64-8. [Abstract] [Full-text]
  346. The matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry (MALDI-TOF MS)-based protein peaks of 4448 and 5302 Da are not associated with the presence of Panton-Valentine leukocidin.
    Int J Med Microbiol, 301(1): 58-63. [Abstract] [Full-text]
Place a permanent text-link or advertisement here.

© 2004-2012 MRSA Research Today. All Rights Reserved.



MRSA Research Today Archive:

Volume 1 (2004)
  Issue 1 (October)
  Issue 2 (November)
  Issue 3 (December)

Volume 2 (2005)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 3 (2006)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 4 (2007)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 5 (2008)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 6 (2009)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 7 (2010)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 8 (2011)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 9 (2012)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)



MRSA Books

Hospital Infection: From Miasmas to MRSA

Hospital Infection: From Miasmas to MRSA